【摘要】 目的观察口服的碘剂—卵磷脂络合碘治疗高度近视性黄斑出血的疗效。方法确诊为高度近视性黄斑出血患者,观察组24例26只眼采用口服卵磷脂络合碘治疗加血管扩张剂及支持疗法;对照组20例22只眼采用血管扩张剂及支持疗法,两组病例均治疗4周、8周后进行检查,观察治疗前后对患者的视力、黄斑出血吸收情况。结果观察组治愈、好转、无效病例分别为19、4、3眼,对照组分别为6、5、11眼。观察组疗效优于对照组(P<0.01)。结论卵磷脂络合碘治疗高度近视性黄斑出血具有较好的疗效。更多还原

【Abstract】 Objective To investigate the therapeutic effect of jolethin on the treatment of macular hemorrhage in pathological myopia.Methods 48 eyes of macular hemorrhage in pathological myopia were separated into two groups,26 eyes of the observation group treated with Jolethin;22 eyes of the control group treated with vasodilator.After 2、4、8weeks,to investigate the therapeutic effect of these two groups.Results These 26 eyes of the observation group treated with jolethin 19 eyes cured,4 eyes turned better,3 eyes failed.The other 22 eyes of the control group treated with vasodilator 6 eyes cured,5 eyes turned better,11 eyes failed.There are statistically difference between two groups(P<0.01).No case was eliminated from the research study due to side effects.Conclusion Jolethin is an effective treatment for macular hemorrhage in pathological myopia.更多还原